Manish Sagar Selected Research

Manish Sagar Research Topics

Disease

12	Infections 01/2022 - 12/2003
4	COVID-19 01/2021 - 10/2020
3	Acquired Immunodeficiency Syndrome (AIDS) 01/2022 - 01/2015
2	HIV Infections (HIV Infection) 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2021 - 11/2018
2	Persistent Infection 10/2016 - 10/2009
2	Reproductive Tract Infections 05/2006 - 03/2004
1	Diabetes Mellitus 01/2022
1	Reinfection 01/2022
1	Weight Gain 01/2022
1	Fever (Fevers) 12/2020
1	Body Weight (Weight, Body) 12/2020
1	Critical Illness (Critically Ill) 10/2020
1	Blood-Borne Infections 01/2020
1	Obesity 01/2020
1	Viremia 01/2020
1	Disease Progression 01/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2015
1	HIV Seropositivity 11/2014
1	Hyperbilirubinemia 10/2014
1	Chronic Disease (Chronic Diseases) 07/2009
1	Sexually Transmitted Diseases (Sexually Transmitted Disease) 03/2004

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 01/2022 - 04/2012
4	RNA (Ribonucleic Acid)IBA 01/2021 - 03/2004
3	Broadly Neutralizing AntibodiesIBA 01/2022 - 04/2012
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2012
2	Interleukin-6 InhibitorsIBA 01/2021 - 10/2020
2	Oxygen (Dioxygen)IBA 12/2020 - 10/2020
2	tocilizumab (atlizumab)FDA Link 12/2020 - 10/2020
2	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 12/2020 - 10/2020
2	Ritonavir (Norvir)FDA Link 01/2015 - 10/2014
2	Glycoproteins (Glycoprotein)IBA 12/2012 - 10/2009
2	CCR5 Receptors (CCR5 Receptor)IBA 12/2012 - 10/2009
2	Contraceptive Agents (Contraceptives)IBA 05/2006 - 03/2004
1	Integrase InhibitorsIBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	VaccinesIBA 01/2022
1	EnzymesIBA 01/2022
1	IntegrasesIBA 01/2022
1	Indicators and Reagents (Reagents)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	sarilumabIBA 10/2020
1	C-Reactive ProteinIBA 01/2020
1	Monoclonal AntibodiesIBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020
1	Nucleic AcidsIBA 01/2020
1	fibrin fragment D (D-dimer)IBA 01/2020
1	Biological ProductsIBA 01/2019
1	CC ChemokinesIBA 06/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 06/2016
1	LipidsIBA 01/2015
1	Interferon-alpha (Interferon Alfa)IBA 11/2014
1	Raltegravir Potassium FDA Link 10/2014
1	Darunavir (Prezista)FDA Link 10/2014
1	Atazanavir Sulfate (Reyataz)FDA Link 10/2014
1	IntegrinsIBA 11/2013
1	CCR5 Receptor AntagonistsIBA 12/2012
1	AntigensIBA 04/2012
1	recombinant soluble CD4IBA 10/2009
1	CD4 Antigens (CD4 Antigen)IBA 10/2009
1	Antiviral Agents (Antivirals)IBA 07/2009
1	Neutralizing AntibodiesIBA 10/2006
1	Viral RNAIBA 12/2003

Therapy/Procedure

1	Art Therapy 01/2022
1	Artificial Respiration (Mechanical Ventilation) 12/2020
1	Aftercare (After-Treatment) 01/2020